Atlas

Model portfolio as of the prior close

Continue reading the Atlas

Sign in or subscribe to read the full post and get every Atlas trade in your inbox.

Showing older Atlas headlines. Recent posts from the last 10 days are available to subscribers.

Shipping Out Premium: A Low-Beta Put on Hafnia

Hafnia Limited sits at $10.07 — barely above our $10 strike — and the market's barely flinching. That's not a bug, it's the feature. With a beta of -0.15, HAFN moves almost independently of broader eq

BOT: Letting the Robots Work While We Collect Premium

RoboStrategy (BOT) is a closed-end fund playing the AI and autonomous systems theme — and right now it's sitting at $26.27 with a $22.50 short put collecting $0.57 in premium at 50 DTE. That's not a m

All Aboard: Carnival's Earnings Pop Makes This Put Worth Writing

Carnival just printed a 13% single-day gain after earnings, and the market's reaction wasn't irrational exuberance — it was a rerating. CCL at $25.11 with a P/E of 10 and analyst targets sitting at $3

PayPal's Purgatory Is Your Premium

PayPal is stuck in that peculiar market limbo where the stock is down bad enough to feel scary but the fundamentals are too cheap to justify ignoring. That tension is exactly what makes today's short

Navitas Gets Army Strong — We're Selling the Dip

## Navitas Gets Army Strong — We're Selling the Dip When the U.S. Army picks your silicon carbide power chips for development, that's not a press release you file and forget. Navitas Semiconductor ju

Relay Therapeutics: Catching a Fallen Knife with a Net

## Relay Therapeutics: Catching a Fallen Knife with a Net RLAY is sitting at $17.47 — down hard from its 50-day moving average of $19.24, but well above its 200-day at $13.70. That's the setup in a n

Spyre Me Up: Selling the $85 Put on SYRE's IBD Breakthrough

Spyre Therapeutics just posted proof-of-concept data across all three components of its IBD combination pipeline — and the market has spent the last few weeks deciding how much it cares. With SYRE sit

ASX: Packaging AI's Backbone, One Premium at a Time

ASE Industrial Holding isn't a household name, but it's probably inside your household's devices. The world's largest semiconductor packaging and testing company sits at a critical chokepoint in the A

Zillow's Rough Patch, Our Premium Patch

Zillow is down bad. The stock is trading at $31.59, sitting 7% below its 50-day MA and a sobering 29% below its 200-day. Rate hike jitters clipped it another 2% recently, and the broader iBuyer sector

Triple B or Not Triple B: Selling Puts on Mexico's Discount Darling

BBB Foods has had a year that would make most growth investors blush — a 98% stock gain that sent at least one director straight for the exit. The stock now sits at $52.47, well above both its 50-day

Atlas Portfolio results shown on this page are a model book marked as of the prior close, produced in a simulation environment using EOD market data and contract pricing. They are not your broker positions, not Option Bot, and not records of trades placed in a brokerage account or executed with real capital, and individual results would vary based on fills, commissions, slippage, and account size. Tiblio is a software platform for finding and executing options trade ideas. We are not a registered investment advisor or broker-dealer. Nothing on this page is financial advice. Options trading involves substantial risk of loss. Past or simulated performance does not guarantee future results.